2016 annual financial data

Supernus Pharmaceuticals 2016 Financial results

Direct answer

Revenue was 215,003,000 USD.

Operating income was 54,216,000 USD and net income was 91,221,000 USD.
Operating cash flow was 66,812,000 USD.

Get free Supernus Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
215,003,000 USD
Operating income
54,216,000 USD
Net income
91,221,000 USD
Operating cash flow
66,812,000 USD